| Product Name | NebuSelect™ Recombinant Mouse JAM-A, His-tag |
|---|---|
| Catalog Number | NBL-242408 |
| Alias/Synonyms | JAM-A; JAM-A; JAM-1; CD321; JAM; JCAM; JCAM1; KAT; PAM-1; F11 receptor; F11R; PAM-1KAT |
| Appearance | see COA |
| Molecule Weight | Lys27-Gly238 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | O88792 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242408-100ug | 100ug | Inquire | Inquire | |
| NBL-242408-1mg | 1mg | Inquire | Inquire | |
| NBL-242408-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse JAM-A, His-tag
Catalog#:
NBL-242408
Description:
NebuSelect™ Recombinant Mouse JAM-A, His-tag(Cat#NBL-242408) is expressed in HEK293 with His tag at the C-Terminus.It contains Lys27-Gly238.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 23.9 kDa. Due to glycosylation, the protein migrates to 28-35 kDa based on Bis-Tris PAGE result.
Target Name:
JAM-A; JAM-A; JAM-1; CD321; JAM; JCAM; JCAM1; KAT; PAM-1; F11 receptor; F11R; PAM-1KAT
Target Information:
junctional adhesion molecule A (JAM-A), a cell adhesion molecule, is highly elevated in human GBM cancer stem cells and predicts poor patient prognosis. While JAM-A is also highly expressed in other cells in the tumor microenvironment, specifically microglia and macrophages,JAM-A functions to suppress pathogenic microglial activation in the female tumor microenvironment, highlighting an emerging role for sex differences in the GBM microenvironment and suggesting that sex differences extend beyond previously reported tumor cell-intrinsic differences.
Amino Acid Sequence:
Lys27-Gly238
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.